<DOC>
	<DOCNO>NCT03015038</DOCNO>
	<brief_summary>Duration part study per patient : - Screening : From 1 4 week - Sampling period ( blood tissue ) : 1 day - Follow-up patient : 60 month - Total study duration patient : 84 month - Total inclusion duration : 24 month - Total Follow-up duration : 60 month - Total study duration : 84 month</brief_summary>
	<brief_title>Study Immune Response Colon Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>1 . Patients age 18 . 2 . Affiliation social security scheme 3 . Diagnosis colon adenocarcinoma . 4 . Patient sign dated consent study undertaking procedure relate study . 1 . Patients guardianship / curatorship 2 . Following Situations Persons unable understand , read / sign inform consent Patient follow function : investigator coinvestigator , research assistant , pharmacist , study coordinator involvement study Uncooperative person potentially noncompliant study procedure predictable difficulty regular monitoring 1 year . No affiliation social security scheme , universal medical coverage similar plan . 3 . Pregnant lactating woman . 4 . Patients HIV seropositivity . 5 . Rectal tumor location .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>